BRCA2 and breast cancer: This current Singapore study, based on 359 Asian breast cancer patients prospectively accrued from a risk-assessment clinic, has identified ER-negativity, TNBC status and a FH of HBOC as predictive factors to increase the likelihood of detecting BRCA1 and BRCA2 mutations.